尊龙Z6官方网站

中文
EN

HOME
ABOUT US
- Leadership
- Investors
- SAB
INVESTOR RELATIONS
- Announcements & Notices
- Financial Reports
- Listing Documents
- Investor Calendar
- Investor Presentation
- Corporate Governance
- Stock Information
- IR Contact
SCIENCE
NEWS & PRESS
- pressReleases
- newsMedia
CAREERS
- Career Openings
CONTACT US

Home

About Us

Leadership Investors SAB

Investor Relations

Announcements & Notices Financial Reports Listing Documents Investor Calendar Investor Presentation Corporate Governance Stock Information IR Contact

Science

Research Areas Pipeline Partnership

News&Press

Press Releases Media

Careers

Career Openings

中文
EN

News & Press

Dr. Yao-chang Xu Attends the Hong Kong Biotech Summit 2018

Mar 23,2018

By Abbisko

Back

On March 22, Dr. Yao-chang Xu, CEO of Abbisko, attended the first Hong Kong Biotech Summit 2018 held by HKEX, when HKEX was revising its listing rules for biotech companies. As a representative of innovative platform-based biotech companies, Abbisko participates in and actively watches the impacts of the rule changes on life science companies and the trends in the industry’s future development.